Advanced Filters
noise
Found 1,281 clinical trials
D Daniel Divacky

Electroconvulsive Therapy Augmented With Transcranial Magnetic Stimulation for Treatment Resistant Depression

The RTMSECT2 study was design to compare the application of electroconvulsive therapy augmented by transcranial magnetic stimulation. Subject will be compared both within groups and in group using psychometric scales and different deliver energy

18 years of age All Phase N/A
J Jing Huang, PhD

aiTBS for Relieving NSSI in Depressive Patients

Repetitive transcranial magnetic stimulation (rTMS) has been successfully used to help patients with treatment resistant depression. However, its role in alleviating self injuries without suicidal ideation remained uncertain. This trial will compare the effectiveness of active accelerated intermittent theta burst stimulation (aiTBS) rTMS to a placebo control on non-suicidal self …

12 - 18 years of age All Phase N/A
S Sophie Wallace, MPH

Antidepressant Effects of Nitrous Oxide

To evaluate the acute and sustained antidepressant effects of nitrous oxide in people with major depressive disorder; and further evaluate these effects by identifying the optimal dose and regimen to guide current practice, and to plan a future large pragmatic trial.

18 years of age All Phase 2
S Stacey Shim

Feasibility Trial of Exercise as a Priming Strategy for rTMS Treatment in Difficult-to-Treat Depression

The goal of this study is to collect feasibility data on combining structured exercise aimed to improve physical fitness, and intermittent TBS (iTBS) in treating individuals diagnosed with difficult-to-treat depression who are physically inactive. By conducting this trial, we will compare the therapeutic benefits of the combined approach against the …

18 - 75 years of age All Phase N/A
N Nick Bassano, MSW

fMRI Neurofeedback With Matter Neuroscience App

Study will utilize an app, Matter Neuroscience, designed to help users with depression understand positive emotions and the neurotransmitters that create them. We hope to learn the safety and efficacy of neurofeedback for treating depression and lay the groundwork for a pivotal clinical trial.

18 - 80 years of age All Phase N/A
D Damien JOLLY

Social Cognition, Memory, and Executive Functions in Bipolar Disorder and Major Depressive Disorder

Bipolar disorder (BD) are common psychiatric disorders often misdiagnosed, leading to delayed treatment. Even during stable phases, individuals with bipolar disorder experience residual cognitive impairments that affect their social functioning and quality of life. This study aims to explore social cognition deficits (e.g., emotional processing, theory of mind, attribution bias) …

18 - 65 years of age All Phase N/A
D Drs. Mariejean Albers

Improving Treatment of Major Depressive Disorder by Reducing Negative Future-Oriented Mental Imagery

Patients with major depressive disorder (MDD) often do not sufficiently benefit from treatment. That is, around 50% of patients with MDD do not respond to treatment and 20-30% only achieve partial remission. Future-oriented negative mental imagery (e.g., mental images of suicide or own funeral) is likely an important maintaining factor …

18 years of age All Phase N/A
H Hasan Mustafić

Nebulized Ketamine for the Treatment of Major Depressive Disorder in an Inpatient Setting

This is a double blind active placebo controlled clinical trial for individuals within an inpatient setting with moderate to severe depression. The purpose of this study is to assess if nebulized ketamine can reduce depressive symptoms.

18 - 88 years of age All Phase 3

Neuromodulation of Different Doses to Treat TRD Guided by pBFS Technique

The aim of this study is to explore the effectiveness and safety of different doses of neural regulation under the guidance of pBFS technology in improving symptoms in patients with moderate to severe depressive disorders.

18 - 65 years of age All Phase N/A

Baby Swim As an Intervention for Depressive Symptoms and Lacking Attachment During the Postpartum Period

Mental health issues are very common during and after pregnancy, and studies from around the world indicate that 10-15% of all pregnant and postpartum women experience depression. Risk factors for developing depression include a history of depression, low levels of social support, and stressful life events. The symptoms are the …

18 years of age Female Phase N/A

Simplify language using AI